Pentwater Capital Management’s Acceleron Pharma XLRN Stock Holding History

Pentwater Capital Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell
2021 Q3	$181M	Buy
2015 Q4	–	Sell
2015 Q3	$2.41M	Sell
2015 Q2	$6.71M	Buy
2015 Q1	$3.12M	Buy
2014 Q4	$3.12M	Buy